Stay updated on Gilead Sciences Press Releases

Sign up to get notified when there's something new on the Gilead Sciences Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Gilead Sciences Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    New press releases were added to the News Releases list for late April and May 2026, including investor conference announcements, a FDA priority review, and an acquisition, while several older releases from March and February 2026 were removed from the listing.
    Difference
    4%
    Check dated 2026-05-01T10:11:08.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    ## Press releases list updated The newsroom “News Releases” pagination and featured items have been updated by adding newer entries (e.g., a Q1 2026 financial results release on May 7, 2026 and regulatory approvals/tender offer extension for the Arcellx acquisition) and removing older listed releases (including an investor-conference presentation and a prior acquisition-focused announcement).
    Difference
    4%
    Check dated 2026-04-24T06:39:11.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    An April 14, 2026 press release about Lenacapavir investment was added to the News Releases list, and the February 10, 2026 dividend press release was removed.
    Difference
    4%
    Check dated 2026-04-17T02:53:18.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a new press release under News Releases (April 7, 2026: Gilead to Acquire Tubulis). Updated the listing count/pagination on the Newsroom page.
    Difference
    4%
    Check dated 2026-04-09T21:51:13.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added a new press release titled 'Gilead Extends Tender Offer to Acquire Arcellx' dated April 1, 2026 to the News Releases list. Removed the press release 'FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma' dated February 6, 2026.
    Difference
    4%
    Check dated 2026-04-02T15:49:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    A new press release entry for March 23, 2026 was added to the Newsroom (Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases), and the January 27, 2026 entry was removed.
    Difference
    4%
    Check dated 2026-03-26T11:51:44.000Z thumbnail image

Stay in the know with updates to Gilead Sciences Press Releases

Enter your email address, and we'll notify you when there's something new on the Gilead Sciences Press Releases page.